L’anticorps anti-TSC22D1 Polyclonal Lapin est utilisé pour la détection de TSC22D1 dans des échantillons de Humain, Rat et Souris. Il a été validé pour WB, IHC, ELISA et IF.
TSC22D1
Reactivité: Humain, Rat, Souris
WB, IHC, ELISA, IF
Hôte: Lapin
Polyclonal
unconjugated
Indications d'application
Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: WB 1:500-1:2000,IHC 1:100-1:300,IF 1:200-1:1000,ELISA 1:20000,Not yet tested in other applications.
Restrictions
For Research Use only
Format
Liquid
Concentration
1 mg/mL
Buffer
Liquid in PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
Agent conservateur
Sodium azide
Précaution d'utilisation
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Stock
-20 °C
Stockage commentaire
Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.
Date de péremption
12 months
Antigène
TSC22D1
(TSC22 Domain Family, Member 1 (TSC22D1))
Autre désignation
TSC-22
Sujet
TSC22D1, KIAA1994, TGFB1I4, TSC22, hucep-2, TSC22 domain family protein 1, Cerebral protein 2, Regulatory protein TSC-22, TGFB-stimulated clone 22 homolog, Transforming growth factor beta-1-induced transcript 4 proteinTSC22D1 (TSC22 domain family member 1) encodes a member of the TSC22 domain family of leucine zipper transcription factors. The encoded protein is stimulated by transforming growth factor beta, and regulates the transcription of multiple genes including C-type natriuretic peptide. The encoded protein may play a critical role in tumor suppression through the induction of cancer cell apoptosis, and a single nucleotide polymorphism in the promoter of TSC22D1 has been associated with diabetic nephropathy. Alternatively spliced transcript variants encoding multiple isoforms have been observed for TSC22D1.